152 related articles for article (PubMed ID: 37867556)
1. UroVysion
Ke C; Liu X; Wan J; Hu Z; Yang C
Front Mol Biosci; 2023; 10():1250442. PubMed ID: 37867556
[No Abstract] [Full Text] [Related]
2. Evaluation of UroVysion for Urachal Carcinoma Detection.
Hu Z; Ke C; Liu Z; Zeng X; Li S; Xu H; Yang C
Front Med (Lausanne); 2020; 7():437. PubMed ID: 32974362
[No Abstract] [Full Text] [Related]
3. The use of Urovysion fluorescence in situ hybridization in the diagnosis and surveillance of non-urothelial carcinoma of the bladder.
Reid-Nicholson MD; Ramalingam P; Adeagbo B; Cheng N; Peiper SC; Terris MK
Mod Pathol; 2009 Jan; 22(1):119-27. PubMed ID: 18978733
[TBL] [Abstract][Full Text] [Related]
4. The Clinical Application of Fluorescence in Situ Hybridization in Diagnosing Urothelial Carcinoma.
Zhou H; Yan Y; Song L
Clin Lab; 2016 Oct; 62(10):2001-2009. PubMed ID: 28164542
[TBL] [Abstract][Full Text] [Related]
5. UroVysion fluorescence in situ hybridization (UroVysion FISH) assay for detection of bladder cancer in voided urine of Turkish patients: a preliminary study.
Dodurga Y; Avcı CB; Yılmaz S; Nazlı O; Coğulu O; Cankaya T; Gündüz C
Contemp Oncol (Pozn); 2013; 17(2):156-60. PubMed ID: 23788983
[TBL] [Abstract][Full Text] [Related]
6. The value of the UroVysion® FISH assay in the risk-stratification of patients with "atypical urothelial cells" in urinary cytology specimens.
Virk RK; Abro S; de Ubago JMM; Pambuccian SE; Quek ML; Wojcik EM; Mehrotra S; Chatt GU; Barkan GA
Diagn Cytopathol; 2017 Jun; 45(6):481-500. PubMed ID: 28397365
[TBL] [Abstract][Full Text] [Related]
7. Examination of Diagnostic Accuracy of UroVysion Fluorescence In Situ Hybridization for Bladder Cancer in a Single Community of Japanese Hospital Patients.
Nagai T; Okamura T; Yanase T; Chaya R; Moritoki Y; Kobayashi D; Akita H; Yasui T
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1271-1273. PubMed ID: 31030505
[TBL] [Abstract][Full Text] [Related]
8. Comparison of urinary cytology and fluorescence in situ hybridization in the detection of urothelial neoplasia: An analysis of discordant results.
McHale T; Ohori NP; Cieply KM; Sherer C; Bastacky SI
Diagn Cytopathol; 2019 Apr; 47(4):282-288. PubMed ID: 30417563
[TBL] [Abstract][Full Text] [Related]
9. UroVysion
Ke C; Hu Z; Yang C
Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358841
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Utility of UroVysion Combined With Conventional Urinary Cytology for Urothelial Carcinoma of the Upper Urinary Tract.
Sassa N; Iwata H; Kato M; Murase Y; Seko S; Nishikimi T; Hattori R; Gotoh M; Tsuzuki T
Am J Clin Pathol; 2019 Apr; 151(5):469-478. PubMed ID: 30668617
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of urovysion and cytology for bladder cancer detection: a study of 1835 paired urine samples with clinical and histologic correlation.
Dimashkieh H; Wolff DJ; Smith TM; Houser PM; Nietert PJ; Yang J
Cancer Cytopathol; 2013 Oct; 121(10):591-7. PubMed ID: 23801650
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal abnormalities in renal cell carcinoma variants detected by Urovysion fluorescence in situ hybridization on paraffin-embedded tissue.
Reid-Nicholson MD; Motiwala N; Drury SC; Peiper SC; Terris MK; Waller JL; Ramalingam P
Ann Diagn Pathol; 2011 Feb; 15(1):37-45. PubMed ID: 21238914
[TBL] [Abstract][Full Text] [Related]
13. DNA image cytometry and fluorescence in situ hybridization for noninvasive detection of urothelial tumors in voided urine.
Dalquen P; Kleiber B; Grilli B; Herzog M; Bubendorf L; Oberholzer M
Cancer; 2002 Dec; 96(6):374-9. PubMed ID: 12478686
[TBL] [Abstract][Full Text] [Related]
14. UroVysion fluorescence in situ hybridization in urothelial carcinoma: a narrative review and future perspectives.
Nagai T; Naiki T; Etani T; Iida K; Noda Y; Shimizu N; Isobe T; Nozaki S; Okamura T; Ando R; Kawai N; Yasui T
Transl Androl Urol; 2021 Apr; 10(4):1908-1917. PubMed ID: 33968678
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date.
Gomella LG; Mann MJ; Cleary RC; Hubosky SG; Bagley DH; Thumar AB; McCue PA; Lallas CD; Trabulsi EJ
Can J Urol; 2017 Feb; 24(1):8620-8626. PubMed ID: 28263126
[TBL] [Abstract][Full Text] [Related]
16. [Clinical value of fluorescence in situ hybridization positive of exfoliated urothelial cells in urothelial carcinoma].
Liu JY; Peng X; Ning XH; Li T; Peng SH; Wang JY; Liu SJ; Ding Y; Cai L; Gong K
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Aug; 49(4):585-589. PubMed ID: 28816270
[TBL] [Abstract][Full Text] [Related]
17. Modified UroVysion scoring criteria increase the urothelial carcinoma detection rate in cases of equivocal urinary cytology.
Huysentruyt CJ; Baldewijns MM; Rüland AM; Tonk RJ; Vervoort PS; Smits KM; van de Beek C; Speel EJ
Histopathology; 2011 Jun; 58(7):1048-53. PubMed ID: 21707706
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value comparison of CellDetect, fluorescent in situ hybridization (FISH), and cytology in urothelial carcinoma.
Shang D; Liu Y; Xu X; Chen Z; Wang D
Cancer Cell Int; 2021 Sep; 21(1):465. PubMed ID: 34488763
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma.
Veeramachaneni R; Nordberg ML; Shi R; Herrera GA; Turbat-Herrera EA
Diagn Cytopathol; 2003 Jun; 28(6):301-7. PubMed ID: 12768634
[TBL] [Abstract][Full Text] [Related]
20. Urinary fluorescence in situ hybridization assay for detecting urothelial carcinoma in Taiwanese patients.
Chuang KL; Chuang HC; Ng KF; Chang YH; Wu CT; Chuang CK; Liao SK; Pang ST
BJU Int; 2010 May; 105(10):1413-6. PubMed ID: 19818076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
